Bacterial diarrhea

New England Journal of Medicine

Volumn 361, Issue 16, 2009, Pages 1560-1569

  DuPont, Herbert L ^a,b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b Kelsey Research Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BISMUTH SALICYLATE; CEFTRIAXONE; CIPROFLOXACIN; DIPHENOXYLATE; DOXYCYCLINE; ERYTHROMYCIN; LEVOFLOXACIN; LOPERAMIDE; METRONIDAZOLE; RIFAXIMIN; TETRACYCLINE; VANCOMYCIN; SHIGA TOXIN;

ADULT; ANAMNESIS; ARTICLE; CAMPYLOBACTER ENTERITIS; CASE REPORT; CHOLERA; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE ASSOCIATION; DYSENTERY; EVENING DOSAGE; FOOD POISONING; HUMAN; INFECTIOUS DIARRHEA; MALE; NONTYPHOID SALMONELLOSIS; PRIORITY JOURNAL; SALMONELLOSIS; SHIGELLOSIS; TRAVELLER DIARRHEA; TYPHOID FEVER; VERNER MORRISON SYNDROME; BACTERIAL INFECTION; BIOSYNTHESIS; CROSS INFECTION; DIARRHEA; ESCHERICHIA COLI; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PRACTICE GUIDELINE; REVIEW; TRAVEL;

BACTERIAL INFECTIONS; CROSS INFECTION; DIARRHEA; DYSENTERY; ESCHERICHIA COLI; FOOD POISONING; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; SHIGA TOXINS; TRAVEL;

EID: 70350451433     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcp0904162     Document Type: Article

References (49)

1. DuPont HL. The growing threat of foodborne bacterial enteropathogens of animal origin. Clin Infect Dis 2007;45:1353-1361
2. Mead PS, Slutsker L, Dietz V, et al. Food-related illness and death in the United States. Emerg Infect Dis 1999;5:607-625 (Pubitemid 29493763)
3. Allos BM, Moore MR, Griffin PM, Tauxe RV. Surveillance for sporadic foodborne disease in the 21st century: the FoodNet perspective. Clin Infect Dis 2004;38:Suppl 3:S115-S120.
4. Zilberberg MD, Shorr AF, Kollef MH. Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis 2008;14:929-931
5. Ailes E, Demma L, Hurd S, et al. Continued decline in the incidence of Campylobacter infections, FoodNet 1996-2006. Foodborne Pathog Dis 2008;5:329-337
6. Thielman NM, Guerrant RL. Acute infectious diarrhea. N Engl J Med 2004;350:38-47.
7. Ethelberg S, Olsen KE, Gerner-Smidt P, Molbak K. The significance of the number of submitted samples and patientrelated factors for faecal bacterial diagnostics. Clin Microbiol Infect 2007;13:1095-1099 (Pubitemid 47543111)
8. Voetsch AC, Van Gilder TJ, Angulo FJ, et al. FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clin Infect Dis 2004;38:Suppl 3:S127-S134.
9. Spano LC, Sadovsky AD, Segui PN, et al. Age-specific prevalence of diffusely adherent Escherichia coli in Brazilian children with acute diarrhoea. J Med Microbiol 2008;57:359-363
10. Meraz IM, Jiang ZD, Ericsson CD, et al. Enterotoxigenic Escherichia coli and diffusely adherent E. coli as likely causes of a proportion of pathogen-negative travelers' diarrhea - a PCR-based study. J Travel Med 2008;15:412-418
11. Willenbrock H, Hallin PF, Wassenaar TM, Ussery DW. Characterization of probiotic Escherichia coli isolates with a novel pan-genome microarray. Genome Biol 2007;8:R267. (Pubitemid 351917510)
12. Talan D, Moran GJ, Newdow M, et al. Etiology of bloody diarrhea among patients presenting to United States emergency departments: prevalence of Escherichia coli O157:H7 and other enteropathogens. Clin Infect Dis 2001;32:573-580
13. Tarr PI. Shiga toxin-associated hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: distinct mechanisms of pathogenesis. Kidney Int Suppl 2009;112:S29-S32.
14. Kendrick JB, Risbano M, Groshong SD, Frankel SK. A rare presentation of ischemic pseudomembranous colitis due to Escherichia coli O157:H7. Clin Infect Dis 2007;45:217-219
15. Garcia-Aljaro C, Muniesa M, Jofre J, Blanch AR. Genotypic and phenotypic diversity among induced, stx2-carrying bacteriophages from environmental Escherichia coli strains. Appl Environ Microbiol 2009;75:329-336
16. Brooks JT, Sowers EG, Wells JG, et al. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. J Infect Dis 2005;192:1422-1429
17. Appleman SS, Ascher D, Park C. Clinical spectrum of Shiga toxin-producing Escherichia coli (STEC) in adults and children. Clin Pediatr (Phila) 2009;48:99-102.
18. Hedberg CW, Palazzi-Churas KL, Radke VJ, Selman CA, Tauxe RV. The use of clinical profiles in the investigation of foodborne outbreaks in restaurants: United States, 1982-1997. Epidemiol Infect 2008;136:65-72.
19. Shah N, DuPont HL, Ramsey DJ. Global etiology of travelers' diarrhea: systematic review from 1973 to the present. Am J Trop Med Hyg 2009;80:609-614
20. DuPont HL, Ericsson CD, Farthing MJ, et al. Expert review of the evidence base for self-therapy of travelers' diarrhea. J Travel Med 2009;16:161-171
21. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007;45:302-307
22. Curry SR, Marsh JW, Shutt KA, et al. High frequency of rifampin resistance identified in an epidemic Clostridium difficile clone from a large teaching hospital. Clin Infect Dis 2009;48:425-429
23. DuPont HL, Jiang ZD, Okhuysen PC, et al. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea. Ann Intern Med 2005;142:805-812 [Erratum, Ann Intern Med 2005;143:239.]
24. DuPont HL, Ericsson CD, Johnson PC, Bitsura JA, DuPont MW, de la Cabada FJ. Prevention of travelers' diarrhea by the tablet formulation of bismuth subsalicylate. JAMA 1987;257:1347-1350
25. DuPont HL, Ericsson CD, Farthing MJ, et al. Expert review of the evidence base for prevention of travelers' diarrhea. J Travel Med 2009;16:149-160
26. McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006;12:409-415
27. Bishara J, Peled N, Pitlik S, Samra Z. Mortality of patients with antibiotic-associated diarrhoea: the impact of Clostridium difficile. J Hosp Infect 2008;68:308-314
28. Chang JY, Antonopoulos DA, Kalra A, et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 2008;197:435-438 (Pubitemid 351263426)
29. Kelly CP, LaMont JT. Clostridium difficile - more difficult than ever. N Engl J Med 2008;359:1932-1940
30. Brown KH, Gastañaduy AS, Saavedra JM, et al. Effect of continued oral feeding on clinical and nutritional outcomes of acute diarrhea in children. J Pediatr 1988;112:191-200.
31. Ochoa TJ, Chen J, Walker CM, Gonzales E, Cleary TG. Rifaximin does not induce toxin production or phage-mediated lysis of Shiga toxin-producing Escherichia coli. Antimicrob Agents Chemother 2007;51:2837-2841 (Pubitemid 47206219)
32. Zhang X, McDaniel AD, Wolf LE, Keusch GT, Waldor MK, Acheson DW. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J Infect Dis 2000;181:664-670 (Pubitemid 30131837)
33. Ohara T, Kojio S, Taneike I, et al. Effects of azithromycin on shiga toxin production by Escherichia coli and subsequent host inflammatory response. Antimicrob Agents Chemother 2002;46:3478-3483 (Pubitemid 35192914)
34. Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food - 10 States, 2008. MMWR Morb Mortal Wkly Rep 2009;58:333-337
35. Jiang ZD, Okhuysen PC, Guo DC, et al. Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. J Infect Dis 2003;188:506-511
36. Jiang ZD, DuPont HL, Garey K, et al. A common polymorphism in the interleukin 8 gene promoter is associated with Clostridium difficile diarrhea. Am J Gastroenterol 2006;101:1112-1116 (Pubitemid 43725328)
37. Mohamed JA, DuPont HL, Jiang ZD, et al. A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico. Clin Infect Dis 2007;44:945-952
38. Mohamed JA, Dupont HL, Jiang ZD, et al. A single-nucleotide polymorphism in the gene encoding osteoprotegerin, an anti-inflammatory protein produced in response to infection with diarrheagenic Escherichia coli, is associated with an increased risk of nonsecretory bacterial diarrhea in North American travelers to Mexico. J Infect Dis 2009;199:477-485
39. Flores J, DuPont HL, Lee SA, et al. Influence of host interleukin-10 polymorphisms on development of traveler's diarrhea due to heat-labile enterotoxin-producing Escherichia coli in travelers from the United States who are visiting Mexico. Clin Vaccine Immunol 2008;15:1194-1198
40. Tam CC, Rodrigues LC, Petersen I, Islam A, Hayward A, O'Brien SJ. Incidence of Guillain-Barré syndrome among patients with Campylobacter infection: a general practice research database study. J Infect Dis 2006;194:95-97 (Pubitemid 43911930)
41. Townes JM, Deodhar AA, Laine ES, et al. Reactive arthritis following culture-confirmed infections with bacterial enteric pathogens in Minnesota and Oregon: a population-based study. Ann Rheum Dis 2008;67:1689-1696
42. Okhuysen PC, Jiang ZD, Carlin L, Forbes C, DuPont HL. Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am J Gastroenterol 2004;99:1774-1778 (Pubitemid 39237507)
43. Spiller RC. Role of infection in irritable bowel syndrome. J Gastroenterol 2007;42:Suppl 17:41-47 (Pubitemid 46140363)
44. Stermer E, Lubezky A, Potasman I, Paster E, Lavy A. Is traveler's diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study. Clin Infect Dis 2006;43:898-901. (Pubitemid 44435519)
45. Jung IS, Kim HS, Park H, Lee SI. The clinical course of postinfectious irritable bowel syndrome: a five-year follow-up study. J Clin Gastroenterol 2009;43:534-540
46. Neal KR, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut 2002;51:410-413 (Pubitemid 34907711)
47. Törnblom H, Holmvall P, Svenungsson B, Lindberg G. Gastrointestinal symptoms after infectious diarrhea: a five-year follow-up in a Swedish cohort of adults. Clin Gastroenterol Hepatol 2007;5:461-464 (Pubitemid 46575368)
48. DuPont HL. Guidelines on acute infectious diarrhea in adults. Am J Gastroenterol 1997;92:1962-1975 (Pubitemid 27476232)
49. Guerrant RL, Van Gilder T, Steiner TS, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001;32:331-351